Editorial Perspectives On Patient Recruitment
-
Siteless DCTs Are Real … And Happening Now
6/20/2024
Siteless DCTs (decentralized trials) are rare, but Praxis Precision Medicines is running one now for patients with essential tremor (ET). Marcio Souza, PharmD, the company’s president and CEO, talks about why they chose this model and the surprising speed at which it is progressing.
-
How Takeda Leverages Cultural Competency Training To Improve Diversity
3/14/2024
Karen Correa, VP, head global clinical operations at Takeda, details some uncommon ways the pharma is tackling the problem of diversity in clinical trials.
-
No Surprise: Patient Recruitment Still Sucks
2/14/2024
Patient recruitment expert Ross Jackson talks about why this part of the clinical trials ecosystem is still a problem and offers up some solutions, specifically around digital/social media outreach.
-
How Re-educating PIs Can Improve Clinical Trial Diversity
12/14/2023
Usually, discussions around ways to improve diversity in clinical trials focus on changing traditional protocol-design processes, finding and tapping into larger pools of diverse patients, educating patients on the value of clinical trials — that type of stuff. You don't normally hear people talking about re-educating physicians as a solution.
-
Can Data Help Improve Diversity In Clinical Trials?
12/7/2023
Denise Bronner Ph.D., director of diversity, equity, and inclusion in clinical trials at Johnson & Johnson Innovative Medicine (JJIM) talks about some of the types of datasets that can be leveraged to improve diversity in clinical trials.
-
AI's Potential To Improve Clinical Operations, Trial Matching
8/11/2023
Microsoft's Dr. Hoifung Poon explains how AI (specifically, large language models) can be used to improve patient care and clinical workflows by making it easier to match patients to trials.
-
Improving Recruitment Through Community Engagement
8/1/2023
UPMC's Dr. Ken Ho shares personal insights about effective community engagement, which allowed him to increase recruitment in the Pitt Men's Study by 35% in just six months.
-
Adapting To The Recruiting Challenges Of Rare Diseases
7/31/2023
Senior VP and head of R&D for Takeda's Plasma-Derived Therapies Business Unit, Dr. Kristina Allikmets, describes the challenges recruiting in the rare (and ultra-rare) disease space.
-
Overcome Recruitment Challenges Of Black And Rural Patients
12/15/2022
Patient recruitment for clinical trials is difficult and can cause many studies to be delayed or cancelled. Two groups that are particularly difficult to recruit are patients of color and those living in remote and rural areas of the country. In those two instances, overcoming recruitment barriers can prove to be particularly difficult.
-
How CVS, Walgreens, And Walmart Will Improve Clinical Trial Recruitment
11/30/2022
A new development could potentially change the patient recruitment challenge. In 2022, CVS, Walgreens, and Walmart officially entered the clinical trials space. The patient access capabilities of all three organizations may change the way drug developers access patients while also solving the patient diversity problem.